abstract |
The present invention provides chimeric antigen receptor polypeptides with antigen recognition domains for CD2, CD3, CD4, CD5, CD7, CD8 and CD52 antigens, and their codes. The invention also provides cells engineered to express polynucleotides or polypeptides. In some embodiments, the invention provides methods for treating diseases associated with CD2, CD3, CD4, CD5, CD7, CD8, and CD52 antigens. |